p53 and rb promoter methylation in hepatitis C virus-related chronic hepatitis and hepatocellular carcinoma

被引:1
|
作者
Aftab, Ayma [1 ]
Afzal, Samia [1 ]
Idrees, Muhammad [1 ]
Shahid, Ahmad Ali [1 ]
机构
[1] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan
关键词
DNA methylation; HCV-3a; p53; rb; tumor suppressor genes; RETINOBLASTOMA TUMOR-SUPPRESSOR; MOLECULAR PATHOGENESIS; PHENOTYPE ASSOCIATION; SIGNALING PATHWAY; GENE-EXPRESSION; DOWN-REGULATION; GROWTH-FACTOR; PROTEIN; NS5A; ACTIVATION;
D O I
10.2217/fvl-2020-0154
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aim: To identify methylation in p53 and rb during hepatitis C virus (HCV) infection in individuals in Pakistan. Materials & methods: Methylation-specific PCR was used on liver biopsies from hepatocellular carcinoma and chronic hepatitis C patients and on blood samples from healthy individuals. Real-time PCR was used to assess changes in the expression of p53 and rb in Huh-7 cells transfected with HCV-3a. Results: The p53 and rb promoters were methylated in hepatocellular carcinoma patients. The presence of HCV-3a-Core (p = 0.03), HCV-3a-NS-3 (p = 0.01) and HCV-3a-NS-5a (p = 0.02) downregulated p53 expression. Exposure to HCV-3a-Core (p = 0.04) downregulated rb expression. Conclusion: It can be hypothesized that HCV-induced epigenetic modifications may lead to the development of hepatic cancer that in turn inactivates p53 and rb.
引用
收藏
页码:15 / 25
页数:12
相关论文
共 50 条
  • [21] Osteopontin Levels in Patients with Hepatitis C Virus-related Hepatocellular Carcinoma
    Filik, Levent
    ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (04) : 334 - 334
  • [22] Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma
    Shawki, Shereen M.
    Meshaal, Safa S.
    El Dash, Aliaa S.
    Zayed, Naglaa A.
    Hanna, Mariam Onsy F.
    DNA AND CELL BIOLOGY, 2014, 33 (12) : 884 - 890
  • [23] Prevention of hepatitis B virus-related hepatocellular carcinoma
    Lin, Chih-Lin
    Kao, Jia-Horng
    HEPATOMA RESEARCH, 2021, 7
  • [24] Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: A pilot study
    Bettinger, Dominik
    Schultheiss, Michael
    Hennecke, Nadine
    Panther, Elisabeth
    Knueppel, Eva
    Blum, Hubert E.
    Thimme, Robert
    Spangenberg, Hans Christian
    HEPATOLOGY, 2013, 57 (06) : 2543 - 2544
  • [25] Prevention of hepatitis B virus-related hepatocellular carcinoma
    Lok, ASF
    GASTROENTEROLOGY, 2004, 127 (05) : S303 - S309
  • [26] Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection
    Sagnelli, E
    Coppola, N
    Pisaturo, M
    Pisapia, R
    Onofrio, M
    Sagnelli, C
    Catuogno, A
    Scolastico, C
    Piccinino, F
    Filippini, P
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : 1536 - 1543
  • [27] Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma
    Zhu, Qianqian
    Li, Fang
    Sang, Jiao
    Deng, Huan
    Han, Qunying
    Lv, Yi
    Li, Chunyan
    Liu, Zhengwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 49 : 126 - 131
  • [28] Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma
    Teng, Y.
    Fan, Y. C.
    Mu, N. N.
    Zhao, J.
    Sun, F. K.
    Wang, K.
    NEOPLASMA, 2016, 63 (03) : 419 - 426
  • [29] Epithelial-mesenchymal transition in hepatitis C virus and hepatitis C virus-related hepatocellular carcinoma in Egyptian patients
    Zoheiry, M.
    Khalil, H.
    El Bassiouni, N.
    El Ahwany, E.
    Nosseir, M.
    Mourad, L.
    El Attar, G.
    Khalil, N.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 97 - 98
  • [30] Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Nishiguchi, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Hamba, H
    Shuto, T
    Yamamoto, T
    Ikebe, T
    Kinoshita, H
    CANCER, 1999, 86 (05) : 793 - 798